We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Tianlong at PhilMedical 2023 Expo | More to Expect!

By LabMedica International staff writers
Posted on 19 Sep 2023
Print article
Image: Tianlong at PhilMedical 2023 Expo (Photo courtesy of Tianlong)
Image: Tianlong at PhilMedical 2023 Expo (Photo courtesy of Tianlong)
From 23 to 25 August 2023, the MEDICAL PHILIPPINES 2023 Expo was held at the SMX Convention Center in Manila, Philippines. As the largest and most professional medical devices expo in Philippines, it attracted the participation of many famous companies in the industry. As an innovative leader in the field of molecular diagnostics in China, Tianlong Technology showcased its advanced technology, products and solutions, as well as professional services on this expo.

At the exhibition, Tianlong’s Panall 8000 All-in-one Molecular Diagnosis System, which can realize "joint detection of multiple pathogens", the compact and flexible Gentier Mini Series Portable Real Time PCR System, as well as the GeneFlex Automatic Nucleic Acid Extractor, received wide attention from the visitors.

On the first day of the expo, the head of Department of Emergency Medical and Trauma Services, Hospital Kuala Lumpur visited Tianlong’s booth and had a deep communication with Tianlong processionals. Hospital Kuala Lumpur is now the largest hospital under the Ministry of Health of Malaysia and is considered to be one of the biggest hospital in Asia.

During the expo, Tianlong's professional team had deep communication with customers, introducing and demonstrating product features, technical advantages and service system.

Tianlong not only achieved good attention on the exhibition, but also developed cooperation opportunities, opening up new channels and opportunities for the future development of the enterprise.

The successful participation in the expo is also an important step in Tianlong's globalization strategy. As an enterprise actively expanding overseas markets, Tianlong will continue to look at the global market and work with more international partners to promote the development of medical technology.

Stay tuned for Tianlong’s following two expos in Thailand this coming September!

Thailand LAB International
Booth No. 3G17
Dates: Sep 6 to 8, 2023
Venue: BITEC, Bangkok, Thailand

Medical Fair Thailand
Booth No. T05
Dates: Sep 13 to 15, 2023
Venue: BITEC, Bangkok, Thailand


New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
PSA Test
Humasis PSA Card
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.